T D Bradshaw et al.
Current medicinal chemistry, 11(8), 1009-1021 (2004-04-14)
This review traces the development of a series of potent and selective antitumour benzothiazoles from the discovery of the initial lead compound, 2-(4-amino-3-methylphenyl)benzothiazole (DF 203) in 1995 to the identification of a clinical candidate, Phortress, scheduled to enter Phase 1...
Synthesis of isotopically labelled [3-14C]-and [3, 3-2H2]-5-fluoro-1, 3-dihydro-1-hydroxy-2, 1-benzoxaborole (AN2690), a new antifungal agent for the potential treatment of onychomycosis.
Baker SJ, et al.
Journal of Labelled Compounds & Radiopharmaceuticals, 50(4), 245-250 (2007)
Synthesis of novel benzylamine analogues of Anacardic acid as potent antibacterial agents.
Der Pharma Chemica, 3(6), 500-512 (2011)